BIK antibody (AA 35-130)
Quick Overview for BIK antibody (AA 35-130) (ABIN704066)
Target
See all BIK AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 35-130
-
Predicted Reactivity
- Human,Mouse,Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Bik
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
-
Alternative Name
- Bik
-
Background
-
Synonyms: Apoptosis inducer NBK, BBC1, Bcl-2-interacting killer, BCL2 interacting killer, bhikhari, BIK, Bik-like killer protein, BIK_HUMAN, BIP 1, BIP1, BP 4, BP4, cb 60, NBK.
Background: The protein encoded by this gene is known to interact with cellular and viral survival-promoting proteins, such as BCL2 and the Epstein-Barr virus in order to enhance programed cell death. Because its activity is suppressed in the presence of survival-promoting proteins, this protein is suggested as a likely target for antiapoptotic proteins. This protein shares a critical BH3 domain with other death-promoting proteins, BAX and BAK.
-
Gene ID
- 638
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-